Epigenetic landscape of amphetamine and methamphetamine addiction in rodents

被引:95
|
作者
Godino, Arthur [1 ]
Jayanthi, Subramaniam [2 ]
Cadet, Jean Lud [2 ]
机构
[1] Ecole Normale Super Lyon, Dept Biol, F-69364 Lyon, France
[2] NIDA, Mol Neuropsychiat Res Branch, NIH, Intramural Res Program, Baltimore, MD 21224 USA
基金
美国国家卫生研究院;
关键词
amphetamine; DNA methylation; histone acetylation; histone methylation; methamphetamine; INDUCED BEHAVIORAL SENSITIZATION; HISTONE DEACETYLASE INHIBITORS; DELTA-FOSB; NUCLEUS-ACCUMBENS; NEUROTROPHIC FACTOR; LOCOMOTOR-ACTIVITY; NEURAL PLASTICITY; SODIUM-BUTYRATE; GENE-EXPRESSION; ANIMAL-MODEL;
D O I
10.1080/15592294.2015.1055441
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Amphetamine and methamphetamine addiction is described by specific behavioral alterations, suggesting long-lasting changes in gene and protein expression within specific brain subregions involved in the reward circuitry. Given the persistence of the addiction phenotype at both behavioral and transcriptional levels, several studies have been conducted to elucidate the epigenetic landscape associated with persistent effects of drug use on the mammalian brain. This review discusses recent advances in our comprehension of epigenetic mechanisms underlying amphetamine- or methamphetamine-induced behavioral, transcriptional, and synaptic plasticity. Accumulating evidence demonstrated that drug exposure induces major epigenetic modificationshistone acetylation and methylation, DNA methylationin a very complex manner. In rare instances, however, the regulation of a specific target gene can be correlated to both epigenetic alterations and behavioral abnormalities. Work is now needed to clarify and validate an epigenetic model of addiction to amphetamines. Investigations that include genome-wide approaches will accelerate the speed of discovery in the field of addiction.
引用
收藏
页码:574 / 580
页数:7
相关论文
共 50 条
  • [31] GENETIC VULNERABILITY OF METHAMPHETAMINE ADDICTION
    Sora, I.
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2012, 36 : 28A - 28A
  • [32] Pharmacological treatment of methamphetamine addiction
    Elkashef, A.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 7 - 7
  • [33] Developing Pharmacotherapies for Methamphetamine Addiction
    Mendelson, John E.
    [J]. BIOLOGICAL PSYCHIATRY, 2010, 67 (09) : 95S - 95S
  • [34] Pharmacotherapy of Methamphetamine Addiction: An Update
    Elkashef, Ahmed
    Vocci, Frank
    Hanson, Glen
    White, Jason
    Wickes, Wendy
    Tiihonen, Jari
    [J]. SUBSTANCE ABUSE, 2008, 29 (03) : 31 - 49
  • [35] Developing Biomarkers for Methamphetamine Addiction
    Mendelson, John
    Baggott, Matthew J.
    Flower, Keith
    Galloway, Gantt
    [J]. CURRENT NEUROPHARMACOLOGY, 2011, 9 (01) : 100 - 103
  • [36] BILIARY EXCRETION OF AMPHETAMINE AND METHAMPHETAMINE IN RAT
    CALDWELL, J
    DRING, LG
    WILLIAMS, RT
    [J]. BIOCHEMICAL JOURNAL, 1971, 124 (02) : P16 - &
  • [37] Methamphetamine Addiction: Biological Foundations
    McKetin, Rebecca
    [J]. DRUG AND ALCOHOL REVIEW, 2010, 29 (02) : 231 - 231
  • [38] COVERT EXTINCTION OF AMPHETAMINE ADDICTION
    GOTESTAM, KG
    MELIN, L
    [J]. BEHAVIOR THERAPY, 1974, 5 (01) : 90 - 92
  • [39] STUDIES ON ELECTROCHEMICAL OXIDATION OF AMPHETAMINE AND METHAMPHETAMINE
    HESS, U
    DOPKE, W
    NAUMANN, M
    SCHMIDT, HU
    [J]. PHARMAZIE, 1976, 31 (07): : 452 - 453
  • [40] High specific activity (+)-amphetamine and (+)-methamphetamine
    Lamb, Pamela B.
    McElhinny, Charles J.
    Sninski, Todd
    Purdom, Hunter
    Carroll, F. Ivy
    Lewin, Anita H.
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2009, 52 (11-12): : 457 - 462